Get the Stockscreener App
7.34
2.37%
0.17
Tevogen Bio Holdings Inc stock is traded at $7.34, with a volume of 1,943.
It is up +2.37% in the last 24 hours and up +4.86% over the past month.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.
See More
Previous Close:
$7.17
Open:
$7.1235
24h Volume:
1,943
Relative Volume:
0.09
Market Cap:
$47.79M
Revenue:
-
Net Income/Loss:
$-26.28M
P/E Ratio:
-1.7113
EPS:
-4.2891
Net Cash Flow:
$-12.39M
1W Performance:
+6.53%
1M Performance:
+4.86%
6M Performance:
-21.16%
1Y Performance:
-83.30%
1-Day Range:
$6.935
$7.34
1-Week Range:
$6.72
$7.34
52-Week Range:
$3.6364
$49.50
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Name
Tevogen Bio Holdings Inc
Sector
Industry
Phone
646-807-8832
Address
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
7.34 | 41.48M | 0 | -26.28M | -12.39M | -4.2891 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-26 | Downgrade | D. Boral Capital | Buy → Hold |
| Mar-04-25 | Initiated | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Stock (TVGN) Latest News
Tevogen Bio Holdings Inc. (NASDAQ: TVGN) Share Price, TVGN Stock News, TVGN Share Price & Updates - Kalkine
Tevogen Bio Holdings (TVGN) Q4 2025 Earnings: Narrower-Than-Expected Loss Drives 4.57% Share GainSubscription Growth Report - vinanet.vn
TVGN Q4 2025 Earnings: Narrower-Than-Expected Loss Signals Improved Cost Discipline for Clinical-Stage Biotech - vinanet.vn
Tevogen Inc (TVGN) narrows first-half loss amid tight cash and heavy R&D - Stock Titan
Tevogen Bio Holdings Inc (TVGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TVGN Q4 2025 Earnings: Narrower-than-Expected Loss Highlights Pre-Revenue StageEPS Consistency Score - vinanet.vn
Form DEF 14A Tevogen Inc. For: 3 August By Investing.com - Investing.com Canada
Tevogen Inc. (NASDAQ: TVGN) targets huge 2024 equity pool expansion - Stock Titan
Tevogen Bio (TVGN) Holds Near $7.02 as Biotech Stock Navigates Tight Trading RangeCall Resistance - vinanet.vn
Tevogen Bio (TVGN) Advances 4.9% to $7.05, Edging Toward Key Resistance at $7.40Statistical Arbitrage - vinanet.vn
Tevogen Bio Q4 2025 Earnings: Narrower-Than-Expected Loss Lifts Shares 4.91%Earnings Volatility Report - vinanet.vn
Tevogen Bio Holdings Rebrands as Tevogen Inc. - theglobeandmail.com
Tevogen Inc. (NASDAQ: TVGN) changes name from Tevogen Bio Holdings - Stock Titan
Tevogen will use new name July 30; TVGN and TVGNW stay - Stock Titan
Tevogen Bio Holdings Inc (TVGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tevogen Bio Holdings Inc (TVGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tevogen Bio Holdings Market Sentiment - Benzinga
Tevogen Bio Holdings Inc (TVGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tevogen Bio Holdings Inc (TVGN) Income Statement - TradingKey
Tevogen Bio Holdings Inc (TVGN) Balance Sheet - TradingKey
Tevogen Bio Holdings Inc (TVGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TVGN|Tevogen Bio Holdings Inc|Price:5.410|Chg%:+0.920 - TradingKey
Tevogen Bio Holdings Inc (TVGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
TVGN|Tevogen Bio Holdings Inc|Price:4.490|Chg%:+0.080 - TradingKey
Tevogen Bio Holdings Inc. Revenue Breakdown – NASDAQ:TVGN - TradingView
Tevogen Bio Holdings Inc (TVGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TVGN|Tevogen Bio Holdings Inc|Price:4.350|Chg%:-0.060 - TradingKey
Tevogen Bio Holdings Inc (TVGN) Institutional Confidence - TradingKey
Enterprise value to EBITDA forward of Tevogen Bio Holdings Inc. – NASDAQ:TVGNW - TradingView
Price to sales forward of Tevogen Bio Holdings Inc. – NASDAQ:TVGNW - TradingView
Form PRE 14A Tevogen Bio Holdings Inc. For: 23 July By Investing.com - Investing.com Nigeria
Tevogen Bio (TVGN) plans 100M-share equity plan boost in 2026 proxy - Stock Titan
Tevogen Bio Holdings(TVGN) Stock Options Chain | Quotes & News - Moomoo
Tevogen Bio Q4 2025 Earnings: EPS Beat Estimates Despite Revenue AbsenceEPS Estimate Trend - vinanet.vn
TVGN Q4 2025 Earnings: EPS Surprise Beats Estimates Despite No Revenue; Shares DeclineEarnings Sentiment Score - vinanet.vn
Form 13D/A Tevogen Bio Holdings Inc. For: 14 July By Investing.com - Investing.com Nigeria
Dr. Saadi boosts control at Tevogen Bio Holdings (TVGN) with stock grant - Stock Titan
Price to book forward of Tevogen Bio Holdings Inc. – NASDAQ:TVGNW - TradingView
Enterprise value to revenue forward of Tevogen Bio Holdings Inc. – NASDAQ:TVGNW - TradingView
Tevogen Bio Announces 2026 Annual Meeting of Stockholders - BioSpace
Tevogen stockholders face a July 23 deadline to submit proposals - Stock Titan
Form 4 Tevogen Bio Holdings Inc For: 10 July By Investing.com - Investing.com South Africa
Tevogen Bio (TVGN) awards 40,000 restricted stock shares to director Victor J. Sordillo - Stock Titan
Tevogen Bio (TVGN) grants CEO Ryan Saadi 1.22M restricted stock units - Stock Titan
Tevogen Bio (TVGN) awards 40,000 performance-based restricted shares to director - Stock Titan
[Form 4] Tevogen Bio Holdings Inc. Insider Trading Activity - Stock Titan
Tevogen Bio (TVGN) awards director 40,000 restricted shares tied to revenue goals - Stock Titan
Tevogen Bio (TVGN) awards CFO 40,000 restricted shares with revenue vesting targets - Stock Titan
Tevogen Bio (TVGN) awards 40,000 restricted shares to director Feike - Stock Titan
Tevogen Bio Warrants (TVGNW) Hold Steady at $0.06: Sideways Action Suggests Minimal EnthusiasmSwing Trade Setups - dars.gov.et
Tevogen Bio Holdings Inc Stock (TVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tevogen Bio Holdings Inc Stock (TVGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Flomenberg Neal | See Remarks |
Mar 13 '26 |
Sale |
6.40 |
501 |
3,206 |
76,940 |
| Flomenberg Neal | See Remarks |
Mar 10 '26 |
Sale |
7.75 |
19 |
147 |
77,893 |
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):